These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Exercise and Hypertrophic Cardiomyopathy: Time for a Change of Heart. Saberi S; Day SM Circulation; 2018 Jan; 137(5):419-421. PubMed ID: 29378753 [No Abstract] [Full Text] [Related]
4. A novel patient-patient network medicine approach to refine hypertrophic cardiomyopathy subgrouping: implications for risk stratification. Wang RS; Rowin EJ; Maron BJ; Maron MS; Maron BA Cardiovasc Res; 2023 May; 119(3):e125-e127. PubMed ID: 37129987 [No Abstract] [Full Text] [Related]
5. [Sudden death (V). Identification and treatment of patients with hypertrophic cardiomyopathy at risk of sudden death]. McKenna WJ; Monserrat Iglesias L Rev Esp Cardiol; 2000 Jan; 53(1):123-30. PubMed ID: 10701329 [TBL] [Abstract][Full Text] [Related]
6. Misconceptions and Facts About Hypertrophic Cardiomyopathy. Argulian E; Sherrid MV; Messerli FH Am J Med; 2016 Feb; 129(2):148-52. PubMed ID: 26299316 [TBL] [Abstract][Full Text] [Related]
9. Implantable defibrillators in long QT syndrome, Brugada syndrome, hypertrophic cardiomyopathy, and arrhythmogenic right ventricular cardiomyopathy. Dohadwala M; Link MS Cardiol Clin; 2014 May; 32(2):305-18. PubMed ID: 24793806 [TBL] [Abstract][Full Text] [Related]
10. Hypertrophic cardiomyopathy and sudden death: new perspectives on risk stratification and prevention with the implantable cardioverter-defibrillator. Maron BJ Eur Heart J; 2000 Dec; 21(24):1979-83. PubMed ID: 11102243 [No Abstract] [Full Text] [Related]
11. Delayed hyperenhancement magnetic resonance imaging for sudden cardiac death risk stratification in hypertrophic cardiomyopathy. Efthimiadis GK; Pagourelias ED J Am Coll Cardiol; 2009 Dec; 55(1):77. PubMed ID: 20117370 [No Abstract] [Full Text] [Related]
15. Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy. Maron BJ; Estes NA; Maron MS; Almquist AK; Link MS; Udelson JE Circulation; 2003 Jun; 107(23):2872-5. PubMed ID: 12814983 [No Abstract] [Full Text] [Related]
16. The never ending story of risk stratification for sudden death in hypertrophic cardiomyopathy. Christiaans I; Wilde AA Am J Cardiol; 2011 Jun; 107(12):1871. PubMed ID: 21640227 [No Abstract] [Full Text] [Related]
17. Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death. McKenna WJ; Behr ER Heart; 2002 Feb; 87(2):169-76. PubMed ID: 11796562 [No Abstract] [Full Text] [Related]
18. Sudden cardiac arrest in a young patient with hypertrophic cardiomyopathy and zero canonical risk factors: the inherent limitations of risk stratification in hypertrophic cardiomyopathy. Kohorst JJ; Bos JM; Hagler DJ; Ackerman MJ Congenit Heart Dis; 2014; 9(2):E51-7. PubMed ID: 23648018 [TBL] [Abstract][Full Text] [Related]
19. Transatlantic differences in assessment of risk of sudden cardiac death in patients with hypertrophic cardiomyopathy. Jahnlová D; Tomašov P; Zemánek D; Veselka J Int J Cardiol; 2015; 186():3-4. PubMed ID: 25804453 [No Abstract] [Full Text] [Related]